DNA X, Inc.
SONM
$4.75
$0.010.21%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -14.78M | -20.66M | -33.38M | -31.14M | -30.28M |
| Total Depreciation and Amortization | 3.25M | 4.30M | 3.72M | 3.68M | 3.73M |
| Total Amortization of Deferred Charges | 2.07M | 2.07M | 4.39M | 4.39M | 6.53M |
| Total Other Non-Cash Items | -14.15M | -4.15M | -1.62M | -380.00K | -659.00K |
| Change in Net Operating Assets | 6.22M | -5.09M | 858.00K | 4.03M | 2.76M |
| Cash from Operations | -17.39M | -23.53M | -26.03M | -19.41M | -17.92M |
| Capital Expenditure | -- | -- | -8.00K | -145.00K | -184.00K |
| Sale of Property, Plant, and Equipment | 3.36M | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 3.36M | -- | -8.00K | -145.00K | -184.00K |
| Total Debt Issued | 3.53M | 6.37M | 5.11M | 2.79M | 2.84M |
| Total Debt Repaid | -555.00K | -555.00K | -591.00K | -591.00K | -- |
| Issuance of Common Stock | 10.13M | 13.67M | 14.01M | 9.18M | 7.54M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 13.11M | 19.49M | 19.12M | 11.97M | 10.97M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -920.00K | -4.04M | -6.92M | -7.59M | -7.14M |